***Background.*** Antibiotics are needed for perioperative intensive care after cardiovascular surgery, but use is sometimes excessive, requiring intervention.

***Methods.*** We analyzed antibiotic use and patient characteristics after scheduled cardiovascular operations (including 76 coronary artery bypass grafting and 96 valve/arch replacements) in our hospital (726 beds and 8 intensive care unit \[ICU\] beds), excluding cases of infective vascular disorders (i.e., infectious endocarditis and mycotic aneurysm) and emergency operations. Observation periods were 8 months in 2013 (intervention period; IP) and the same period in 2012 (pre-IP). For the intervention, an infectious disease \[ID\] fellow rounded on the ICU every day, and three times a week our ASP team (ID physician, clinical ID pharmacist, nurse, and microbiologist) discussed carbapenem and anti-methicillin-resistant *Staphylococcus aureus* \[MRSA\] drug administration for ward patients. Routine perioperative cefazolin was not included in the analysis.

***Results.*** We analyzed 86 cases (540 patient-days \[PDs\] in the ICU and 3576 inpatient PDs) in the IP and 98 cases (619 ICU PDs and 4012 inpatient PDs) in the pre-IP. There were no statistically significant differences between the IP and pre-IP for male sex, age, BMI, operative bleeding, days hospitalized, ICU stay, and survival rate. MRSA and extended spectrum β-lactamase infections \[ESBL\] producing bacteria infections occurred in 9.3% vs 8.2% and 1.7% vs 3.1% of cases in the IP and pre-IP, respectively. Maximum sequential organ failure assessment \[SOFA\] scores during the ICU stay were higher in the IP (8.8 vs 7.6, P = 0.03, Mann-Whitney\'s test). Antibiotic use in the ICU did not differ significantly between periods (183.4 and 222.9 DOT/1,000 PDs), but was lower for the total hospital stay in IP vs pre-IP (142.9 vs 420.2 DOT/1,000 PDs, P \< 0.001, chi-square test), especially for anti-MRSA drugs (17.7 vs 56.3 DOT/1,000 PDs, P \< 0.001). The intervention shortened mean duration of anti-MRSA drug use to 5.2 from 9.8 days in the ICU and to 3.0 from 11.6 days in the ward. Total antibiotic expenditures in 8 months were 1.76 and 3.93 million JPY (IP and pre-IP, respectively).

***Conclusion.*** The ASP team intervention decreased antibiotic use, optimizing anti-MRSA drug use, after cardiovascular surgeries without worsening patient prognosis in critical and ward care.
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